Analysis of overweight/obese pediatric patients with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 study
International Journal of Hematology · 2024
DOI: 10.1007/s12185-024-03745-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Hematology, 2024. Verfasst von Hirozumi Sano und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology/Oncology for Children and Adolescents, Sapporo Hokuyu Hospital, Higashi-Sapporo 6-6, Shiroishi-ku, Sapporo, 003-0006, Japan.…. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Body Mass Index, Overweight. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
The dosage of chemotherapy drugs for overweight/obese children with acute myeloid leukemia (AML) has been empirically reduced based on ideal body weight (BW) in Japan to reduce the risk of adverse events. We investigated the associations between pre-therapeutic body mass index (BMI) and clinical outcomes among children with AML. A total of 280 children were divided into two groups based on the World Health Organization Child Growth Standards: a healthy-weight group (n = 254), and an overweight/obese group (n = 26). If BW exceeded 1.2 times the standard BW of Japanese children, the dosage of chemotherapy drugs was calculated using 1.2 times the standard BW. The dosage of chemotherapy drugs was reduced during at least one chemotherapy cycle in 24 of 26 patients (92.3%) in the overweight/obese group, compared with zero patients in the healthy-weight group. Overall/event-free survival, cumulative incidence of relapse, and treatment-related mortality (TRM) did not differ between the overweight/obese and healthy weight groups. However, the frequency of bacteremia was higher in the overweight/obese group (80.8 vs. 52.4%, P = 0.006). This indicates that TRM may increase when chemotherapy drug dosage is not corrected in overweight/obese patients. Drug reduction is a potential treatment strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology/Oncology for Children and Adolescents, Sapporo Hokuyu Hospital, Higashi-Sapporo 6-6, Shiroishi-ku, Sapporo, 003-0006, Japan. hirozumi.sano@gmail.com.
- Department of Pediatrics, Dokkyo Medical University, Mibu, Japan.
- Department of Pediatrics, Akita University Graduate School of Medicine, Akita, Japan.
- Department of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto, Japan.
- Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan.
- Department of Hematology/Oncology, Kobe Children's Hospital, Kobe, Japan.
Zitieren
APA
Sano, H., Fukushima, K., Yano, M., Osone, S., Kato, Y., Hasegawa, D., Miyamura, T., Iwamoto, S., Takahashi, H., Terui, K., Tawa, A., & Tomizawa, D. (2024). Analysis of overweight/obese pediatric patients with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 study. International Journal of Hematology. https://doi.org/10.1007/s12185-024-03745-9
Vancouver
Sano H, Fukushima K, Yano M, Osone S, Kato Y, Hasegawa D, et al. Analysis of overweight/obese pediatric patients with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 study. International Journal of Hematology. 2024. doi:10.1007/s12185-024-03745-9
BibTeX
@article{Sano2024,
author = {Sano, Hirozumi and Fukushima, Keitaro and Yano, Michihiro and Osone, Shinya and Kato, Yoko and Hasegawa, Daiichiro and Miyamura, Takako and Iwamoto, Shotaro and Takahashi, Hiroyuki and Terui, Kiminori and Tawa, Akio and Tomizawa, Daisuke},
title = {Analysis of overweight/obese pediatric patients with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 study},
journal = {International Journal of Hematology},
year = {2024},
doi = {10.1007/s12185-024-03745-9}
}
EUVIMED